VUBI1

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

VUBI1 is a drug that acts as an activator of the guanine nucleotide exchange factor protein SOS1, increasing the rate at which it catalyzes the exchange of GDP for GTP on its target protein KRAS. While inhibitors of SOS1 have been more widely researched for the treatment of cancer, under some conditions increasing SOS1 activity can also have an anti-cancer effect by destructive overactivation of cellular signaling processes, so SOS1 activators are also of potential clinical interest, as well as being used for the study of the SOS1-KRAS intercellular pathway.

VUBI1 is a drug that acts as an activator of the guanine nucleotide exchange factor protein SOS1, increasing the rate at which it catalyzes the exchange of GDP for GTP on its target protein KRAS. While inhibitors of SOS1 have been more widely researched for the treatment of cancer, under some conditions increasing SOS1 activity can also have an anti-cancer effect by destructive overactivation of cellular signaling processes, so SOS1 activators are also of potential clinical interest, as well as being used for the study of the SOS1-KRAS intercellular pathway.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1369350472 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.